BTG Competitors and Similar CompaniesClear all

BTG's competitors and similar companies include Zogenix, Affimed N.V., Avid Bioservices and Skyepharma.
BTG
BTG
BTG is an international specialist healthcare company.
Zogenix
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
Affimed N.V.
Affimed N.V.
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Avid Bioservices
Avid Bioservices
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
Skyepharma
Skyepharma
Skyepharma is a drug delivery company developing oral and inhalation products.
Founding Date
Founding Date
1948
Founding Date
2006
Founding Date
2000
Founding Date
1981
Founding Date
1996
Type
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Düsseldorf, DE
Yokne'am Illit, IL
see more
Locations
Emeryville, US HQ
Maidenhead, GB
Locations
Heidelberg, DE HQ
Locations
Tustin, US HQ
Locations
Saint-Quentin-Fallavier, FR HQ
Employees
Employees
638
Employees
14157% increase
Employees
219
Employees
21114% increase
Employees
2001% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
86.9 m
Valuation ($)
481.9 m
Valuation ($)
N/A
Twitter followers
Twitter followers
1.1 k
Twitter followers
2
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Employee Rating
Employee Rating
3.2
Employee Rating
2.7
Employee Rating
N/A
Employee Rating
3.3
Employee Rating
3.1

Financial

Revenue (est.)
Revenue (est.)
£731.3m (FY, 2019)
Revenue (est.)
$81.7m (FY, 2021)
Revenue (est.)
€41.4m (FY, 2022)
Revenue (est.)
$149.3m (FY, 2023)
Revenue (est.)
£95.9m (FY, 2015)
Cost of goods
Cost of goods
£221m (FY, 2019)
Cost of goods
$4.8m (FY, 2021)
Cost of goods
N/A
Cost of goods
$117.8m (FY, 2023)
Cost of goods
£43.1m (FY, 2015)
Gross profit
Gross profit
£510.3m (FY, 2019)
Gross profit
N/A
Gross profit
€42.8m (FY, 2022)
Gross profit
$31.5m (FY, 2023)
Gross profit
£52.8m (FY, 2015)
Net income
Net income
£88.3m (FY, 2019)
Net income
($227.4m) (FY, 2021)
Net income
(€86m) (FY, 2022)
Net income
$560k (FY, 2023)
Net income
N/A
For sources of this data, please see the company profile

View Company Profiles

Zogenix
HQ
Emeryville, US

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company
Affimed N.V.
HQ
Heidelberg, DE
Employees
219

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

View company
Avid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.

View company
Skyepharma
HQ
Saint-Quentin-Fallavier, FR

Skyepharma is a drug delivery company developing oral and inhalation products.

View company